Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Biotechnology

Editor-in-Chief

ISSN (Print): 1389-2010
ISSN (Online): 1873-4316

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Lipid Engineered Nanoparticle Therapy for Burn Wound Treatment

Author(s): Abdul Qadir, Usama Ahmad, Asad Ali, Aisha Shahid, Mohd. Aqil, Nausheen Khan, Athar Ali, Waleed H. Almalki, Saad Alghamdi, Md. Abul Barkat and Sarwar Beg*

Volume 23, Issue 12, 2022

Published on: 23 August, 2021

Page: [1449 - 1459] Pages: 11

DOI: 10.2174/1389201022666210823110532

Price: $65

Abstract

Introduction: Skin is the largest organ of the human body protecting the underlying organs and tissues from any foreign attack. Any damage caused in the skin may sometimes result in serious consequences within the internal body tissues. Burn is one such issue that damages the layers of the skin and thereby making the skin vulnerable and prone to any foreign matter entering and causing serious diseases.

Methods: An online literature assessment was steered for the lipid nanoparticles, burn wound treatments, and different types of nanoformulation. Appropriate information was taken from different electronic scientific databases such as Web of Science, Elsevier, Science Direct, Springer, PubMed, Google Scholar etc. Additional data was summarized from textbooks, local prints and scripts.

Results: Recent innovations and developments in nanotechnology-based drug delivery systems have shown promising results in minimizing the drawbacks associated with conventional therapies. Lipid based nanoparticles possess capabilities to deliver active agents to their target site without the possibility of degradation. Conventional therapy of burn wound is costly and the treatment is long lasting, making the patient uncomfortable. Moreover, it also doesn’t yield satisfactory results or narrow effects. Encapsulation of bioactives inside the lipid core protects the active entity from pH and enzymatic degradations.

Conclusion: This review highlights the drawbacks associated with conventional dosage forms. A lot of consideration is focused on the advancement of nanomaterials using innovative methods in wound care for treating burn wounds with a faster healing effect. This review article highlights recent developments in lipid based nanoformulations for the treatment of burn wound injury.

Keywords: Burn, injury, nanoparticles, lipids, wound healing, liposomes, niosomes, ethosomes.

« Previous Next »
Graphical Abstract

[1]
Jeschke, M.G. Burn injury (Primer). Nat. Rev. Dis. Primers, 2020, 6(1), 1-25.
[http://dx.doi.org/10.1038/s41572-020-0145-5] [PMID: 31907359]
[2]
Lee, R.C. Injury by electrical forces: pathophysiology, manifestations, and therapy. Curr. Probl. Surg., 1997, 34(9), 677-764.
[http://dx.doi.org/10.1016/S0011-3840(97)80007-X] [PMID: 9365421]
[3]
Jeschke, M.G.; Kamolz, L.P.; Sjoberg, F.; Wolf, S.E., Eds.; Handbook of burns volume 1: acute burn care; Sprin. Sci. Busi. Media, 2012, p. 1.
[4]
Jeschke, M.G.; Gauglitz, G.G.; Kulp, G.A.; Finnerty, C.C.; Williams, F.N.; Kraft, R.; Suman, O.E.; Mlcak, R.P.; Herndon, D.N. Long-term persistance of the pathophysiologic response to severe burn injury. PLoS One, 2011, 6(7), e21245.
[http://dx.doi.org/10.1371/journal.pone.0021245] [PMID: 21789167]
[5]
Jeschke, M.G.; Chinkes, D.L.; Finnerty, C.C.; Kulp, G.; Suman, O.E.; Norbury, W.B.; Branski, L.K.; Gauglitz, G.G.; Mlcak, R.P.; Herndon, D.N. Pathophysiologic response to severe burn injury. Ann. Surg., 2008, 248(3), 387-401.
[http://dx.doi.org/10.1097/SLA.0b013e3181856241] [PMID: 18791359]
[6]
Stanojcic, M.; Abdullahi, A.; Rehou, S.; Parousis, A.; Jeschke, M.G. Pathophysiological response to burn injury in adults. Ann. Surg., 2018, 267(3), 576-584.
[http://dx.doi.org/10.1097/SLA.0000000000002097] [PMID: 29408836]
[7]
Porter, C.; Tompkins, R.G.; Finnerty, C.C.; Sidossis, L.S.; Suman, O.E.; Herndon, D.N. The metabolic stress response to burn trauma: current understanding and therapies. Lancet, 2016, 388(10052), 1417-1426.
[http://dx.doi.org/10.1016/S0140-6736(16)31469-6] [PMID: 27707498]
[8]
Burnett, E.; Gawaziuk, J.P.; Shek, K.; Logsetty, S. Healthcare resource utilization associated with burns and necrotizing fasciitis: a single-center comparative analysis. J. Burn Care Res., 2017, 38(6), e886-e891.
[http://dx.doi.org/10.1097/BCR.0000000000000513] [PMID: 28296669]
[9]
Enns, J.; Gawaziuk, J.P.; Khan, S.; Chateau, D.; Bolton, J.M.; Sareen, J.; Stone, J.; Doupe, M.; Logsetty, S. Mental and physical health outcomes in parents of children with burn injuries as compared with matched controls. J. Burn Care Res., 2016, 37(1), e18-e26.
[http://dx.doi.org/10.1097/BCR.0000000000000309] [PMID: 26361326]
[10]
Logsetty, S.; Shamlou, A.; Gawaziuk, J.P.; March, J.; Doupe, M.; Chateau, D.; Hoppensack, M.; Khan, S.; Medved, M.; Leslie, W.D.; Enns, M.W.; Stein, M.B.; Asmundson, G.J.; Sareen, J. Mental health outcomes of burn: A longitudinal population-based study of adults hospitalized for burns. Burns, 2016, 42(4), 738-744.
[http://dx.doi.org/10.1016/j.burns.2016.03.006] [PMID: 27049068]
[11]
Mason, S.A.; Nathens, A.B.; Byrne, J.P.; Diong, C.; Fowler, R.A.; Karanicolas, P.J.; Moineddin, R.; Jeschke, M.G. Increased rate of long-term mortality among burn survivors: a population-based matched cohort study. Ann. Surg., 2019, 269(6), 1192-1199.
[http://dx.doi.org/10.1097/SLA.0000000000002722] [PMID: 31082920]
[12]
National academies of sciences, engineering, and medicine. A national trauma care system: integrating military and civilian trauma systems to achieve zero preventable deaths after injury; National Academies Press, 2016.
[13]
D’Avignon, L.C.; Hogan, B.K.; Murray, C.K.; Loo, F.L.; Hospenthal, D.R.; Cancio, L.C.; Kim, S.H.; Renz, E.M.; Barillo, D.; Holcomb, J.B.; Wade, C.E.; Wolf, S.E. Contribution of bacterial and viral infections to attributable mortality in patients with severe burns: an autopsy series. Burns, 2010, 36(6), 773-779.
[http://dx.doi.org/10.1016/j.burns.2009.11.007] [PMID: 20074860]
[14]
Merchant, N.; Smith, K.; Jeschke, M.G. An ounce of prevention saves tons of lives: infection in burns. Surg. Infect. (Larchmt.), 2015, 16(4), 380-387.
[http://dx.doi.org/10.1089/sur.2013.135] [PMID: 26207399]
[15]
Norbury, W.; Herndon, D.N.; Tanksley, J.; Jeschke, M.G.; Finnerty, C.C. Infection in burns. Surg. Infect. (Larchmt.), 2016, 17(2), 250-255.
[http://dx.doi.org/10.1089/sur.2013.134] [PMID: 26978531]
[16]
Pruitt, B.A. Jr Reflection: evolution of the field over seven decades. Surg. Clin. North Am., 2014, 94(4), 721-740.
[http://dx.doi.org/10.1016/j.suc.2014.05.001] [PMID: 25085084]
[17]
Branski, L.K.; Al-Mousawi, A.; Rivero, H.; Jeschke, M.G.; Sanford, A.P.; Herndon, D.N. Emerging infections in burns. Surg. Infect. (Larchmt.), 2009, 10(5), 389-397.
[http://dx.doi.org/10.1089/sur.2009.024] [PMID: 19810827]
[18]
Kinch, M.S.; Patridge, E.; Plummer, M.; Hoyer, D. An analysis of FDA-approved drugs for infectious disease: antibacterial agents. Drug Discov. Today, 2014, 19(9), 1283-1287.
[http://dx.doi.org/10.1016/j.drudis.2014.07.005] [PMID: 25043770]
[19]
Azzopardi, E.A.; Azzopardi, E.; Camilleri, L.; Villapalos, J.; Boyce, D.E.; Dziewulski, P.; Dickson, W.A.; Whitaker, I.S. Gram negative wound infection in hospitalised adult burn patients-systematic review and metanalysis-. PLoS One, 2014, 9(4), e95042.
[http://dx.doi.org/10.1371/journal.pone.0095042] [PMID: 24751699]
[20]
Issler-Fisher, A.C.; Fakin, R.M.; Fisher, O.M.; McKew, G.; Gazzola, R.; Rauch, A.K.; Gottlieb, T.; Haertsch, P.; Guggenheim, M.; Giovanoli, P.; Maitz, P.K. Microbiological findings in burn patients treated in a general versus a designated intensive care unit: Effect on length of stay. Burns, 2016, 42(8), 1805-1818.
[http://dx.doi.org/10.1016/j.burns.2016.06.019] [PMID: 27372144]
[21]
Bang, R.L.; Sharma, P.N.; Sanyal, S.C.; Bang, S.; Ebrahim, M.K. Burn septicaemia in Kuwait: associated demographic and clinical factors. Med. Princ. Pract., 2004, 13(3), 136-141.
[http://dx.doi.org/10.1159/000076952] [PMID: 15073425]
[22]
Klasen, H.J. A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver. Burns, 2000, 26(2), 131-138.
[http://dx.doi.org/10.1016/S0305-4179(99)00116-3] [PMID: 10716355]
[23]
Marx, D.E.; Barillo, D.J. Silver in medicine: the basic science. Burns, 2014, 40(Suppl. 1), S9-S18.
[http://dx.doi.org/10.1016/j.burns.2014.09.010] [PMID: 25418438]
[24]
Fox, C.L. Jr Silver sulfadiazine-a new topical therapy for Pseudomonas in burns. Therapy of Pseudomonas infection in burns. Arch. Surg., 1968, 96(2), 184-188.
[http://dx.doi.org/10.1001/archsurg.1968.01330200022004] [PMID: 5638080]
[25]
Wasiak, J.; Cleland, H.; Campbell, F.; Spinks, A. Dressings for superficial and partial thickness burns. Cochrane Database Syst. Rev., 2013, (3), CD002106.
[http://dx.doi.org/10.1002/14651858.CD002106.pub4] [PMID: 23543513]
[26]
Aziz, Z.; Abu, S.F.; Chong, N.J. A systematic review of silver-containing dressings and topical silver agents (used with dressings) for burn wounds. Burns, 2012, 38(3), 307-318.
[http://dx.doi.org/10.1016/j.burns.2011.09.020] [PMID: 22030441]
[27]
Atiyeh, B.S.; Costagliola, M.; Hayek, S.N.; Dibo, S.A. Effect of silver on burn wound infection control and healing: review of the literature. burns, 2007, 33(2), 139-148.
[28]
Yoshino, Y.; Ohtsuka, M.; Kawaguchi, M.; Sakai, K.; Hashimoto, A.; Hayashi, M.; Madokoro, N.; Asano, Y.; Abe, M.; Ishii, T.; Isei, T.; Ito, T.; Inoue, Y.; Imafuku, S.; Irisawa, R.; Ohtsuka, M.; Ogawa, F.; Kadono, T.; Kawakami, T.; Kukino, R.; Kono, T.; Kodera, M.; Takahara, M.; Tanioka, M.; Nakanishi, T.; Nakamura, Y.; Hasegawa, M.; Fujimoto, M.; Fujiwara, H.; Maekawa, T.; Matsuo, K.; Yamasaki, O.; Le Pavoux, A.; Tachibana, T.; Ihn, H. The wound/burn guidelines - 6: Guidelines for the management of burns. J. Dermatol., 2016, 43(9), 989-1010.
[http://dx.doi.org/10.1111/1346-8138.13288] [PMID: 26971391]
[29]
Finley, P.J.; Norton, R.; Austin, C.; Mitchell, A.; Zank, S.; Durham, P. Unprecedented silver resistance in clinically isolated Enterobacteriaceae: major implications for burn and wound management. Antimicrob. Agents Chemother., 2015, 59(8), 4734-4741.
[http://dx.doi.org/10.1128/AAC.00026-15] [PMID: 26014954]
[30]
Diederen, B.M.; Wardle, C.L.; Krijnen, P.; Tuinebreijer, W.E.; Breederveld, R.S. Epidemiology of clinically relevant bacterial pathogens in a burn center in the Netherlands between 2005 and 2011. J. Burn Care Res., 2015, 36(3), 446-453.
[http://dx.doi.org/10.1097/BCR.0000000000000144] [PMID: 25162950]
[31]
Trevino, S.E.; Kollef, M.H. Management of infections with drug-resistant organisms in critical care: an ongoing battle. Clin. Chest Med., 2015, 36(3), 531-541.
[http://dx.doi.org/10.1016/j.ccm.2015.05.007] [PMID: 26304289]
[32]
Azzopardi, E.A.; Boyce, D.E.; Thomas, D.W.; Dickson, W.A. Colistin in burn intensive care: back to the future. Burns, 2013, 39(1), 07-15.
[33]
Capoor, M.R.; Gupta, S.; Sarabahi, S.; Mishra, A.; Tiwari, V.K.; Aggarwal, P. Epidemiological and clinico-mycological profile of fungal wound infection from largest burn centre in Asia. Mycoses, 2012, 55(2), 181-188.
[PMID: 21740469]
[34]
Schaal, J.V.; Leclerc, T.; Soler, C.; Donat, N.; Cirrode, A.; Jault, P.; Bargues, L. Epidemiology of filamentous fungal infections in burned patients: A French retrospective study. Burns, 2015, 41(4), 853-863.
[http://dx.doi.org/10.1016/j.burns.2014.10.024] [PMID: 25681957]
[35]
Ballard, J.; Edelman, L.; Saffle, J.; Sheridan, R.; Kagan, R.; Bracco, D.; Cancio, L.; Cairns, B.; Baker, R.; Fillari, P.; Wibbenmeyer, L.; Voight, D.; Palmieri, T.; Greenhalgh, D.; Kemalyan, N.; Caruso, D. Positive fungal cultures in burn patients: a multicenter review. J. Burn Care Res., 2008, 29(1), 213-221.
[http://dx.doi.org/10.1097/BCR.0b013e31815f6ecb] [PMID: 18182925]
[36]
Pedrosa, A.F.B.; Rodrigues, A.G. Candidemia in burn patients: figures and facts. J. Trauma Acute Care Surg., 2011, 70(2), 498-506.
[http://dx.doi.org/10.1097/TA.0b013e3181f2d4fb] [PMID: 21307753]
[37]
Horvath, E.E.; Murray, C.K.; Vaughan, G.M.; Chung, K.K.; Hospenthal, D.R.; Wade, C.E.; Holcomb, J.B.; Wolf, S.E.; Mason, A.D., Jr; Cancio, L.C. Fungal wound infection (not colonization) is independently associated with mortality in burn patients. Ann. Surg., 2007, 245(6), 978-985.
[http://dx.doi.org/10.1097/01.sla.0000256914.16754.80] [PMID: 17522525]
[38]
Song, J.C.; Stevens, D.A. Caspofungin: Pharmacodynamics, pharmacokinetics, clinical uses and treatment outcomes. Crit. Rev. Microbiol., 2016, 42(5), 813-846.
[http://dx.doi.org/10.3109/1040841X.2015.1068271] [PMID: 26369708]
[39]
Blanchet, B.; Jullien, V.; Vinsonneau, C.; Tod, M. Influence of burns on pharmacokinetics and pharmacodynamics of drugs used in the care of burn patients. Clin. Pharmacokinet., 2008, 47(10), 635-654.
[http://dx.doi.org/10.2165/00003088-200847100-00002] [PMID: 18783295]
[40]
Steele, A.N.; Grimsrud, K.N.; Sen, S.; Palmieri, T.L.; Greenhalgh, D.G.; Tran, N.K. Gap analysis of pharmacokinetics and pharmacodynamics in burn patients: a review. J. Burn Care Res., 2015, 36(3), e194-e211.
[http://dx.doi.org/10.1097/BCR.0000000000000120] [PMID: 25942648]
[41]
Martyn, J. Clinical pharmacology and drug therapy in the burned patient. Anesthesiology, 1986, 65(1), 67-75.
[http://dx.doi.org/10.1097/00000542-198607000-00011] [PMID: 2873763]
[42]
Holtman, J.R., Jr; Jellish, W.S. Opioid-induced hyperalgesia and burn pain. J. Burn Care Res., 2012, 33(6), 692-701.
[http://dx.doi.org/10.1097/BCR.0b013e31825adcb0] [PMID: 23143613]
[43]
Pardeike, J.; Hommoss, A.; Müller, R.H. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int. J. Pharm., 2009, 366(1-2), 170-184.
[http://dx.doi.org/10.1016/j.ijpharm.2008.10.003] [PMID: 18992314]
[44]
Ferreira, M.; Silva, E.; Barreiros, L.; Segundo, M.A.; Costa Lima, S.A.; Reis, S. Methotrexate loaded lipid nanoparticles for topical management of skin-related diseases: Design, characterization and skin permeation potential. Int. J. Pharm., 2016, 512(1), 14-21.
[http://dx.doi.org/10.1016/j.ijpharm.2016.08.008] [PMID: 27530292]
[45]
Jain, A.K.; Jain, A.; Garg, N.K.; Agarwal, A.; Jain, A.; Jain, S.A.; Tyagi, R.K.; Jain, R.K.; Agrawal, H.; Agrawal, G.P. Adapalene loaded solid lipid nanoparticles gel: an effective approach for acne treatment. Colloids Surf. B Biointerfaces, 2014, 121, 222-229.
[http://dx.doi.org/10.1016/j.colsurfb.2014.05.041] [PMID: 25016424]
[46]
Lauterbach, A.; Müller-Goymann, C.C. Applications and limitations of lipid nanoparticles in dermal and transdermal drug delivery via the follicular route. Eur. J. Pharm. Biopharm., 2015, 97(Pt A), 152-163.
[http://dx.doi.org/10.1016/j.ejpb.2015.06.020] [PMID: 26144664]
[47]
Luo, Y.; Chen, D.; Ren, L.; Zhao, X.; Qin, J. Solid lipid nanoparticles for enhancing vinpocetine’s oral bioavailability. J. Control. Release, 2006, 114(1), 53-59.
[http://dx.doi.org/10.1016/j.jconrel.2006.05.010] [PMID: 16828192]
[48]
Silva, A.C.; González-Mira, E.; García, M.L.; Egea, M.A.; Fonseca, J.; Silva, R.; Santos, D.; Souto, E.B.; Ferreira, D. Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): high pressure homogenization versus ultrasound. Colloids Surf. B Biointerfaces, 2011, 86(1), 158-165.
[http://dx.doi.org/10.1016/j.colsurfb.2011.03.035] [PMID: 21530187]
[49]
Schwarz, C.; Mehnert, W.; Lucks, J.S.; Müller, R.H. Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization. J. Control. Release, 1994, 30(1), 83-96.
[http://dx.doi.org/10.1016/0168-3659(94)90047-7]
[50]
zur Mühlen, A.; Schwarz, C.; Mehnert, W. Solid lipid nanoparticles (SLN) for controlled drug delivery-drug release and release mechanism. Eur. J. Pharm. Biopharm., 1998, 45(2), 149-155.
[http://dx.doi.org/10.1016/S0939-6411(97)00150-1] [PMID: 9704911]
[51]
Ghasemiyeh, P.; Mohammadi-Samani, S. Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages. Res. Pharm. Sci., 2018, 13(4), 288-303.
[http://dx.doi.org/10.4103/1735-5362.235156] [PMID: 30065762]
[52]
Barrientos, S.; Stojadinovic, O.; Golinko, M.S.; Brem, H.; Tomic-Canic, M. Growth factors and cytokines in wound healing. Wound Repair Regen., 2008, 16(5), 585-601.
[http://dx.doi.org/10.1111/j.1524-475X.2008.00410.x] [PMID: 19128254]
[53]
Ishikawa, T.; Terai, S.; Urata, Y.; Marumoto, Y.; Aoyama, K.; Sakaida, I.; Murata, T.; Nishina, H.; Shinoda, K.; Uchimura, S.; Hamamoto, Y.; Okita, K. Fibroblast growth factor 2 facilitates the differentiation of transplanted bone marrow cells into hepatocytes. Cell Tissue Res., 2006, 323(2), 221-231.
[http://dx.doi.org/10.1007/s00441-005-0077-0] [PMID: 16228231]
[54]
Moya, M.L.; Garfinkel, M.R.; Liu, X.; Lucas, S.; Opara, E.C.; Greisler, H.P.; Brey, E.M. Fibroblast growth factor-1 (FGF-1) loaded microbeads enhance local capillary neovascularization. J. Surg. Res., 2010, 160(2), 208-212.
[http://dx.doi.org/10.1016/j.jss.2009.06.003] [PMID: 19959194]
[55]
Fu, X.; Shen, Z.; Chen, Y.; Xie, J.; Guo, Z.; Zhang, M.; Sheng, Z. Randomised placebo-controlled trial of use of topical recombinant bovine basic fibroblast growth factor for second-degree burns. Lancet, 1998, 352(9141), 1661-1664.
[http://dx.doi.org/10.1016/S0140-6736(98)01260-4] [PMID: 9853438]
[56]
Alemdaroğlu, C.; Degim, Z.; Celebi, N.; Şengezer, M.; Alömeroglu, M.; Nacar, A. Investigation of epidermal growth factor containing liposome formulation effects on burn wound healing. J. Biomed. Mater. Res. A, 2008, 85(1), 271-283.
[http://dx.doi.org/10.1002/jbm.a.31588] [PMID: 17937411]
[57]
Kleemann, E.; Schmehl, T.; Gessler, T.; Bakowsky, U.; Kissel, T.; Seeger, W. Iloprost-containing liposomes for aerosol application in pulmonary arterial hypertension: formulation aspects and stability. Pharm. Res., 2007, 24(2), 277-287.
[http://dx.doi.org/10.1007/PL00022055] [PMID: 17211729]
[58]
Visser, C.C.; Stevanović, S.; Voorwinden, L.H.; van Bloois, L.; Gaillard, P.J.; Danhof, M.; Crommelin, D.J.; de Boer, A.G. Targeting liposomes with protein drugs to the blood-brain barrier in vitro. Eur. J. Pharm. Sci., 2005, 25(2-3), 299-305.
[http://dx.doi.org/10.1016/j.ejps.2005.03.008] [PMID: 15911226]
[59]
Ricci, M.; Giovagnoli, S.; Blasi, P.; Schoubben, A.; Perioli, L.; Rossi, C. Development of liposomal capreomycin sulfate formulations: effects of formulation variables on peptide encapsulation. Int. J. Pharm., 2006, 311(1-2), 172-181.
[http://dx.doi.org/10.1016/j.ijpharm.2005.12.031] [PMID: 16439072]
[60]
Xiang, Q.; Xiao, J.; Zhang, H.; Zhang, X.; Lu, M.; Zhang, H.; Su, Z.; Zhao, W.; Lin, C.; Huang, Y.; Li, X. Preparation and characterisation of bFGF-encapsulated liposomes and evaluation of wound-healing activities in the rat. Burns, 2011, 37(5), 886-895.
[http://dx.doi.org/10.1016/j.burns.2011.01.018] [PMID: 21377274]
[61]
Taddonio, T.E.; Thomson, P.D.; Smith, D.J., Jr; Prasad, J.K. A survey of wound monitoring and topical antimicrobial therapy practices in the treatment of burn injury. J. Burn Care Rehabil., 1990, 11(5), 423-427.
[http://dx.doi.org/10.1097/00004630-199009000-00009] [PMID: 2246312]
[62]
Gurfinkel, R.; Palivatkel-Naim, M.; Gleisinger, R.; Rosenberg, L.; Singer, A.J. Comparison of purified olive oil and silver sulfadiazine in the treatment of partial thickness porcine burns. Am. J. Emerg. Med., 2012, 30(1), 79-83.
[http://dx.doi.org/10.1016/j.ajem.2010.10.003] [PMID: 21159471]
[63]
Gear, A.J.; Hellewell, T.B.; Wright, H.R.; Mazzarese, P.M.; Arnold, P.B.; Rodeheaver, G.T.; Edlich, R.F. A new silver sulfadiazine water soluble gel. Burns, 1997, 23(5), 387-391.
[http://dx.doi.org/10.1016/S0305-4179(97)89763-X] [PMID: 9426907]
[64]
Warriner, R.; Burrell, R. Infection and the chronic wound: a focus on silver. Adv. Skin Wound Care, 2005, 18(8)(Suppl. 1), 2-12.
[http://dx.doi.org/10.1097/00129334-200510001-00001] [PMID: 16220035]
[65]
Hussain, Z.; Abourehab, M.A.S.; Khan, S.; Thu, E.H. Chapter 9 - Silver nanoparticles: a promising nanoplatform for targeted delivery of therapeutics and optimized therapeutic efficacy. In: Metal Nanoparticles for Drug Delivery and Diagnostic Applications: Micro and Nano Technologies. Shah, M.R.; Imran, M.; Ullah, S. 2020, 141-173.
[http://dx.doi.org/10.1016/B978-0-12-816960-5.00009-4]
[66]
Cooper, M.L.; Laxer, J.A.; Hansbrough, J.F. The cytotoxic effects of commonly used topical antimicrobial agents on human fibroblasts and keratinocytes. J. Trauma, 1991, 31(6), 775-782.
[http://dx.doi.org/10.1097/00005373-199106000-00007] [PMID: 2056541]
[67]
McCauley, R.L.; Linares, H.A.; Pelligrini, V.; Herndon, D.N.; Robson, M.C.; Heggers, J.P. In vitro toxicity of topical antimicrobial agents to human fibroblasts. J. Surg. Res., 1989, 46(3), 267-274.
[http://dx.doi.org/10.1016/0022-4804(89)90069-3] [PMID: 2921865]
[68]
Dunn, K.; Edwards-Jones, V. The role of acticoat with nanocrystalline silver in the management of burns. Burns, 2004, 30(Suppl. 1), S1-S9.
[http://dx.doi.org/10.1016/S0305-4179(04)90000-9] [PMID: 15327800]
[69]
Kuroyanagi, Y.; Kim, E.; Shioya, N. Evaluation of a synthetic wound dressing capable of releasing silver sulfadiazine. J. Burn Care Rehabil., 1991, 12(2), 106-115.
[http://dx.doi.org/10.1097/00004630-199103000-00004] [PMID: 1904876]
[70]
Drummond, C.J.; Fong, C. Surfactant self-assembly objects as novel drug delivery vehicles. Curr. Opin. Colloid Interface Sci., 1999, 4(6), 449-456.
[http://dx.doi.org/10.1016/S1359-0294(00)00020-0]
[71]
Almgren, M. Vesicle transformations resulting from curvature tuning in systems with micellar, lamellar, and bicontinuous cubic phases. J. Dispers. Sci. Technol., 2007, 28(1), 43-54.
[http://dx.doi.org/10.1080/01932690600992613]
[72]
Contescu, C.I.; Putyera, K. Dekker encyclopedia of nanoscience and nanotechnology; -six volume set; Taylor & Francis, 2009.
[http://dx.doi.org/10.1201/NOE0849396397]
[73]
Razumas, V.; Talaikytė, Z.; Barauskas, J.; Larsson, K.; Miezis, Y.; Nylander, T. Effects of distearoylphosphatidylglycerol and lysozyme on the structure of the monoolein-water cubic phase: X-ray diffraction and Raman scattering studies. Chem. Phys. Lipids, 1996, 84(2), 123-188.
[http://dx.doi.org/10.1016/S0009-3084(96)02629-1] [PMID: 9022219]
[74]
Sadhale, Y.; Shah, J.C. Stabilization of insulin against agitation-induced aggregation by the GMO cubic phase gel. Int. J. Pharm., 1999, 191(1), 51-64.
[http://dx.doi.org/10.1016/S0378-5173(99)00288-4] [PMID: 10556740]
[75]
Sadhale, Y.; Shah, J.C. Biological activity of insulin in GMO gels and the effect of agitation. Int. J. Pharm., 1999, 191(1), 65-74.
[http://dx.doi.org/10.1016/S0378-5173(99)00287-2] [PMID: 10556741]
[76]
Almgren, M.; Rangelov, S. Polymorph Dispersed Particles from the Bicontinuous Cubic Phase of Glycerol Monooleate Stabilized by PEG‐Copolymers with Lipid‐Mimetic Hydrophobic Anchors. J. Dispers. Sci. Technol., 2006, 27(5), 599-609.
[http://dx.doi.org/10.1080/01932690600662513]
[77]
Morsi, N.M.; Abdelbary, G.A.; Ahmed, M.A. Silver sulfadiazine based cubosome hydrogels for topical treatment of burns: development and in vitro/in vivo characterization. Eur. J. Pharm. Biopharm., 2014, 86(2), 178-189.
[http://dx.doi.org/10.1016/j.ejpb.2013.04.018] [PMID: 23688805]
[78]
Ali, A.; Ansari, V.A.; Ahmad, U.; Akhtar, J.; Jahan, A. Nanoemulsion: An advanced vehicle for efficient drug delivery. Drug Res. (Stuttg.), 2017, 67(11), 617-631.
[http://dx.doi.org/10.1055/s-0043-115124] [PMID: 28738427]
[79]
Hamouda, T.; Hayes, M.M.; Cao, Z.; Tonda, R.; Johnson, K.; Wright, D.C.; Brisker, J.; Baker, J.R. Jr A novel surfactant nanoemulsion with broad-spectrum sporicidal activity against Bacillus species. J. Infect. Dis., 1999, 180(6), 1939-1949.
[http://dx.doi.org/10.1086/315124] [PMID: 10558951]
[80]
Hamouda, T.; Myc, A.; Donovan, B.; Shih, A.Y.; Reuter, J.D.; Baker, J.R. Jr A novel surfactant nanoemulsion with a unique non-irritant topical antimicrobial activity against bacteria, enveloped viruses and fungi. Microbiol. Res., 2001, 156(1), 1-7.
[http://dx.doi.org/10.1078/0944-5013-00069] [PMID: 11372645]
[81]
Hamouda, T.; Baker, J.R., Jr Antimicrobial mechanism of action of surfactant lipid preparations in enteric Gram-negative bacilli. J. Appl. Microbiol., 2000, 89(3), 397-403.
[http://dx.doi.org/10.1046/j.1365-2672.2000.01127.x] [PMID: 11021571]
[82]
Hemmila, M.R.; Mattar, A.; Taddonio, M.A.; Arbabi, S.; Hamouda, T.; Ward, P.A.; Wang, S.C.; Baker, J.R., Jr Topical nanoemulsion therapy reduces bacterial wound infection and inflammation after burn injury. Surgery, 2010, 148(3), 499-509.
[http://dx.doi.org/10.1016/j.surg.2010.01.001] [PMID: 20189619]
[83]
Dolgachev, V.A.; Ciotti, S.M.; Eisma, R.; Gracon, S.; Wilkinson, J.E.; Baker, J.R., Jr; Hemmila, M.R. Nanoemulsion therapy for burn wounds is effective as a topical antimicrobial against gram-negative and gram-positive bacteria. J. Burn Care Res., 2016, 37(2), e104-e114.
[http://dx.doi.org/10.1097/BCR.0000000000000217] [PMID: 26182074]
[84]
Dharashivkar, S.S.; Sahasrabuddhe, S.H.; Saoji, A.N. Niosomally encapsulated silver sulfadiazine gel for burn treatment. J. Microencapsul., 2015, 32(2), 137-142.
[http://dx.doi.org/10.3109/02652048.2014.958202] [PMID: 25265059]
[85]
Sohrabi, S.; Haeri, A.; Mahboubi, A.; Mortazavi, A.; Dadashzadeh, S. Chitosan gel-embedded moxifloxacin niosomes: An efficient antimicrobial hybrid system for burn infection. Int. J. Biol. Macromol., 2016, 85, 625-633.
[http://dx.doi.org/10.1016/j.ijbiomac.2016.01.013] [PMID: 26794314]
[86]
Caddeo, C.; Manca, M.L.; Peris, J.E.; Usach, I.; Diez-Sales, O.; Matos, M.; Fernàndez-Busquets, X.; Fadda, A.M.; Manconi, M. Tocopherol-loaded transfersomes: In vitro antioxidant activity and efficacy in skin regeneration. Int. J. Pharm., 2018, 551(1-2), 34-41.
[http://dx.doi.org/10.1016/j.ijpharm.2018.09.009] [PMID: 30201294]
[87]
Chaudhari, Y.; Dharashivkar, S.; Palkar, P.; Chaudhari, M.; Ruhatiya, G.; Patil, M.; Gaikwad, M. Formulation and evaluation of transfersomalcream of acriflavine. Intern. Res. J. Pharm., 2016, 7(8), 75-78.
[http://dx.doi.org/10.7897/2230-8407.078100]
[88]
Partoazar, A.; Kianvash, N.; Darvishi, M.H.; Nasoohi, S.; Rezayat, S.M.; Bahador, A. Ethosomalcurcumin promoted wound healing and reduced bacterial flora in second degree burn in rat. Drug Res. (Stuttg.), 2016, 66(12), 660-665.
[http://dx.doi.org/10.1055/s-0042-114034] [PMID: 27626605]
[89]
Razavi, S.; Partoazar, A.; Takzaree, N.; Fasihi-Ramandi, M.; Bahador, A.; Darvishi, M.H. Silver sulfadiazine nanoethogel for burn healing: characterization and investigation of its in vivo effects. Nanomedicine (Lond.), 2018, 13(11), 1319-1331.
[http://dx.doi.org/10.2217/nnm-2017-0385] [PMID: 29949464]
[90]
El-Refaie, W.M.; Elnaggar, Y.S.; El-Massik, M.A.; Abdallah, O.Y. Novel curcumin-loaded gel-core hyaluosomes with promising burn-wound healing potential: Development, in-vitro appraisal and in-vivo studies. Int. J. Pharm., 2015, 486(1-2), 88-98.
[http://dx.doi.org/10.1016/j.ijpharm.2015.03.052] [PMID: 25818063]
[91]
Mazumder, A.; Dwivedi, A.; du Preez, J.L.; du Plessis, J. In vitro wound healing and cytotoxic effects of sinigrin-phytosome complex. Int. J. Pharm., 2016, 498(1-2), 283-293.
[http://dx.doi.org/10.1016/j.ijpharm.2015.12.027] [PMID: 26706438]
[92]
Devi, S.L.; Divakar, M.C. Wound healing activity studies rats.Hygeia. J. D. Med., 2012, 4(2), 87-94.

Rights & Permissions Print Cite
Article Metrics
59
1
© 2024 Bentham Science Publishers | Privacy Policy